Abstract
In an oncology setting, technetium-99m methylene diphosphonate (Tc-99m MDP) bone scans are done to assist in the diagnosis of bone metastases. Extra-skeletal Tc -99m MDP uptake is occasionally seen and is usually due to an artifact or a flaw in the procedure [1]. True extra-skeletal findings are unusual and relate mainly to the excretion of radio active tracer via the urinary system [1, 2]. Here, we present such a case of an unexpected finding of liver metastases in a patient who had a bone scan as part of her investigation into the cause of her hypercalcaemia. A brief review of the literature accompanies this report.
Current Radiopharmaceuticals
Title: An Unexpected Diagnosis of Liver Metastases on a Bone Scan
Volume: 2 Issue: 3
Author(s): Sangeetha Poovaneswaran and Philip J. Atherton
Affiliation:
Abstract: In an oncology setting, technetium-99m methylene diphosphonate (Tc-99m MDP) bone scans are done to assist in the diagnosis of bone metastases. Extra-skeletal Tc -99m MDP uptake is occasionally seen and is usually due to an artifact or a flaw in the procedure [1]. True extra-skeletal findings are unusual and relate mainly to the excretion of radio active tracer via the urinary system [1, 2]. Here, we present such a case of an unexpected finding of liver metastases in a patient who had a bone scan as part of her investigation into the cause of her hypercalcaemia. A brief review of the literature accompanies this report.
Export Options
About this article
Cite this article as:
Poovaneswaran Sangeetha and Atherton J. Philip, An Unexpected Diagnosis of Liver Metastases on a Bone Scan, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030220
DOI https://dx.doi.org/10.2174/1874471010902030220 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Four Major Factors Regulate Phosphatidylinositol 3-kinase Signaling Pathway in Cancers Induced by Infection of Human Papillomaviruses
Current Medicinal Chemistry Preclinical Evaluation of a Zinc Finger Inhibitor Targeting Lentivirus Nucleocapsid Protein in SIV-Infected Monkeys
Current HIV Research Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Tumor-Targeted Drug Delivery with Aptamers
Current Medicinal Chemistry Administration of Drug and Nutritional Components in Nano-Engineered Form to Increase Delivery Ratio and Reduce Current Inefficient Practice
Recent Patents on Drug Delivery & Formulation Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?
Current Cancer Drug Targets Copper Complexes as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry An Update on Overcoming MDR1-Mediated Multidrug Resistance in Cancer Chemotherapy
Current Pharmaceutical Design The Role of Epigenetics in Drug Resistance in Cancer
Epigenetic Diagnosis & Therapy (Discontinued) A Review of the Current Role of Proton Therapy in Modern Oncology
Current Drug Therapy Closely Related Antiretroviral Agents as Inhibitors of Two HIV-1 Enzymes, Ribonuclease H and Integrase: “Killing Two Birds with One Stone”
Current Pharmaceutical Design Subject Index to Volume 3
Current Drug Targets - Infectious Disorders Oxidative Stress and Cancer: The Role of Nrf2
Current Cancer Drug Targets Unequivocal Role of Pyrazine Ring in Medicinally Important Compounds: A Review
Mini-Reviews in Medicinal Chemistry Strategies to Overcome or Circumvent P-Glycoprotein Mediated Multidrug Resistance
Current Medicinal Chemistry Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety FDG-PET in Tuberculosis
Current Molecular Imaging (Discontinued) Stable Expression of the Sodium/Iodide Symporter (NIS) for anti-Cancer Gene Therapy of Glioma Cells Using a Third Generation Self-Inactivating Lentiviral Vector System in Combination with 211At
Current Radiopharmaceuticals RETRACTED: Aberrant Sialylation in Cancer Pathology and Metastasis, a Putative Drug Target Candidate
Anti-Cancer Agents in Medicinal Chemistry